Commentary: The reintroduction of Lotronex for diarrhea-predominant irritable bowel syndrome

BMJ

Volumn 327, Issue 7418, 2003, Pages E163-

  Woodcock, Janet ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85007758050     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmjusa.02110002     Document Type: Article

References (1)

1. Risk Management of Prescription Drugs; Public Hearing Transcript. Available at: www.fda.gov/ohrms/dockets/dockets/02n0115/02n0115-tr.htm (accessed October 15, 2002).